Back to Search
Start Over
An Improved DNA Vaccine Against Bovine Herpesvirus-1 Using CD40L and a Chemical Adjuvant Induces Specific Cytotoxicity in Mice
- Source :
- Viral Immunology. 34:68-78
- Publication Year :
- 2021
- Publisher :
- Mary Ann Liebert Inc, 2021.
-
Abstract
- Bovine herpesvirus-1 (BoHV-1) uses many mechanisms to elude the immune system; one of them is spreading intracellularly, even in the presence of specific antiviral antibodies. Cytotoxic T lymphocytes (CTLs) are necessary to eliminate the virus. The main preventive strategy is vaccination based on inactivated virus. These vaccines are poor inducers of cellular immune responses, and complicate serological diagnosis and determination of the real prevalence of infection. DNA vaccines are a good option because of the capacity of Differentiating Infected from Vaccinated Animals-(DIVA vaccine)-and may be the best way to induce cytotoxic responses. Although this type of vaccines leads to only weak "
- Subjects :
- 0301 basic medicine
medicine.medical_treatment
CD40 Ligand
Immunology
Antibodies, Viral
DNA vaccination
Mice
03 medical and health sciences
0302 clinical medicine
Immune system
Adjuvants, Immunologic
Virology
Vaccines, DNA
medicine
Animals
Cytotoxic T cell
Cytotoxicity
Herpesvirus 1, Bovine
CD40
biology
biology.organism_classification
Bovine herpesvirus 1
030104 developmental biology
biology.protein
Molecular Medicine
Cattle
030211 gastroenterology & hepatology
Antibody
Adjuvant
Subjects
Details
- ISSN :
- 15578976 and 08828245
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Viral Immunology
- Accession number :
- edsair.doi.dedup.....ec3bbd0672f4a5764cf71382555c993c
- Full Text :
- https://doi.org/10.1089/vim.2020.0082